Pharmaceutical Technology

JULY 6, 2022

Scientists at the National Institutes of Health (NIH) unit National Institute of Neurological Disorders and Stroke (NINDS) have found that Covid-19-induced immune response could damage the blood vessels of the brain and may lead to short and long-term neurological symptoms. .

Immune Response 162

Immune Response Antibody Gene DNA 162

Pharmaceutical Technology

APRIL 11, 2023

Health experts have lent their support to the new programme as the existing vaccines may not be as effective against future virus threats. The programme is expected to develop long-lasting monoclonal antibodies and expedite the development of vaccines that produce mucosal immunity to reduce transmission and infection risks.

Vaccination 264

Vaccination Vaccine Development Antibody 264

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. They intend to develop vaccines that provide lasting immune responses compared to existing vaccines.

Vaccination 245

Vaccination Vaccine Development RNA 245

Pharmaceutical Technology

APRIL 14, 2023

Long Covid is a health condition characterised by the continuation or development of new symptoms three months after an initial SARS-CoV-2 infection. The work is supported by the role of foralumab in dampening activated microglia cells, said to be an important component of the pathogenesis of this disease.

Life Science 246

Life Science Clinical Trials Clinical Trials Trials 246

Drug Discovery World

APRIL 26, 2024

Researchers have found that vitamin D encourages the growth of a type of gut bacteria in mice which improves immunity to cancer. This microbe gave mice better immunity to cancer as the transplanted tumours didn’t grow as much, but the researchers are not yet sure how.

Bacteria 52

Bacteria Research Regulation Drugs 52

Pharmaceutical Technology

NOVEMBER 14, 2022

The Phase I signal prompted the start of the multicenter placebo-controlled Phase II MiSLE study, funded by the Lupus Foundation and the US National Institutes of Health. In lupus, the body’s immune system starts to attack its own cells. Cell & Gene Therapy coverage on Clinical Trials Arena is supported by Cytiva.

Antibody 362

Antibody Gene Therapy Manufacturing Trials 362

Drug Discovery World

JANUARY 25, 2024

These are well known health challenges related to long-term spaceflight, and share biological mechanisms implicated in highly prevalent age-related diseases. The company will provide materials including candidates derived from its platform to support the collaborative research at UCF.

Medicine 52

Medicine Research In-Vivo In-Vitro 52

Pharmaceutical Technology

OCTOBER 10, 2022

Health Canada has approved Pfizer ’s subsidiary Pfizer Canada and BioNTech’s bivalent Covid-19 vaccine, Comirnaty, as a 30?g 5-adapted bivalent vaccine available to the people in Canada to support the continued vaccination programme in advance of the winter season. g booster shot for 12 years and above aged individuals.

Vaccination 147

Vaccination Vaccine Gene Therapy Protein 147

Pharmaceutical Technology

APRIL 11, 2023

Led by General Catalyst, the financing round was supported by Intermountain Health, FACIT, and other investors. The company will use the funding to further optimise and validate its technology platform, alongside expanding its team to support its initiative of offering curative therapies for cancer patients.

Development 130

Development Gene Therapy Engineer Clinical Development 130

Scienmag

JUNE 21, 2022

Daily use of a mushroom extract supported the immune system in clearing human papillomavirus (HPV) infections, according to researchers with UTHealth Houston. The randomized, double-blind, placebo-controlled Phase II study was supported by a grant from the National Institutes of Health (1R03CA212935).

Research 64

Research 64

Drug Discovery World

JUNE 23, 2023

The winners of the EIT Health Catapult 2023 competition were announced at the Bits & Pretzels Conference, where Immunyx, a developer of immune modulating therapies for neutrophil based diseases, won in the biotech category. We stand ready to support these start-ups in their mission to transform healthcare.”

Development 52

Development Drugs 52

Drug Discovery World

DECEMBER 19, 2023

Immusoft’s Immune System Programming (ISP) approach is designed to enable reprogramming of a patient’s B cells for constant production of therapeutic proteins, mitigating the need for frequent enzyme administration and the potential to improve patient outcomes.

Engineer 113

Engineer Trials Genetic Disease Gene Therapy 113

Pharmaceutical Technology

MAY 19, 2023

The US Food and Drug Administration (FDA) has approved AbbVie’s Rinvoq (upadacitinib) for patients with Crohn’s disease who do not respond to TNF blockers, a common immune suppressant treatment for the condition. Data from two Phase III studies, U-EXCEED and U-EXCEL, involving 857 patients was used to support the approval.

FDA Approval 264

FDA Approval Dermatology Sales Clinical Trials 264

Pharmaceutical Technology

JULY 12, 2022

Health Canada has accepted to review Arcutis Biotherapeutics’ New Drug Submission (NDS) for roflumilast cream 0.3% (ARQ-151) to treat plaque psoriasis in adult and adolescent patients. A validated target in dermatology, PDE4 is an enzyme that induces overactive immune responses.

Dermatology 162

Dermatology Immune Response Trials Clinical Trials 162

Medical Xpress

MARCH 6, 2023

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. A non-temperature stable form of the candidate previously had been tested in several clinical trials.

Immune Response 75

Immune Response Vaccination Vaccine Trials 75

Pharmaceutical Technology

JUNE 20, 2023

The proposed institute will focus on vaccine research, public health research, therapeutics, genomics, diagnostics, clinical trials and data. Designed by Australian architectural company Wardle, the new institute will be a collaboration between the Doherty Institute and the Burnet Institute.

Biobanking 130

Biobanking Genome Genomics Clinical Trials 130

Pharmaceutical Technology

NOVEMBER 7, 2022

Health Canada has granted authorisation for Moderna ’s BA.4/BA.5 mRNA-1273.222 is said to be the second bivalent Covid-19 shot of the company to obtain Health Canada approval. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccination 130

Vaccination Vaccine Gene Therapy Clinical Trials 130

Scienmag

MARCH 31, 2022

Zinc’s immune-boosting properties are well-established, but scientists haven’t known exactly how it works. In a new study published online March 25 in the journal Blood, Fred Hutchinson Cancer Research Center scientists reveal two ways the mineral supports immunity and suggest how it could be used to improve health.

Scientist 53

Scientist Research 53

Scienmag

OCTOBER 14, 2020

Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction, supports a mechanism critical for survival in mouse models of sepsis and colitis Credit: UC San Diego Health Sciences The immune response to infections is a delicate balance.

Protein 67

Protein Immune Response Bacteria Allergies 67

Pharmaceutical Technology

DECEMBER 8, 2022

Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. In November, Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) for treating adults with HER2-positive unresectable or recurrent breast cancer.

Licensing 305

Licensing Licensing Gene Therapy Gene 305

BioTech 365

SEPTEMBER 20, 2021

Moducare Balances Immunity for Daily Enhanced Support Moducare Balances Immunity for Daily Enhanced Support MISSION VIEJO, Calif., 20, 2021 (GLOBE NEWSWIRE) — Once a seasonal topic, immune health is now top of mind for many people as virus protection … Continue reading →

40

40

Drug Discovery World

MARCH 11, 2024

Following a separate submission process the World Health Organization has proposed the International Nonproprietary Name (INN) of cambritaxestat. This Orphan Drug Designation will support our goal to accelerate cambritaxestat through the clinic to provide a new treatment to patients with limited options.”

Drugs 69

Drugs Research Development 69

Drug Discovery World

JULY 12, 2023

Healing can be inefficient due to inflammation caused by an overreaction of the body’s immune system, which normally protects against infections. However, drugs that reduce inflammation by suppressing the whole immune response also inhibit the immune cells which promote repair.

Immune Response 52

Immune Response Drugs Scientist Regulation 52

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. Human-first precision health. Verily’s Immune Profiler can, Kim asserted, “generate more than 8 million immune measures across 24 immune cell subsets”.

Development 134

Development Research Drugs Clinical Trials 134

The Pharma Data

APRIL 22, 2023

WHO/UNICEF have started the Immunization Annual Data Collection Process We are pleased to announce that the World Health Organization (WHO) / United Nations Children’s Fund (UNICEF) electronic Joint Reporting Form on Immunization (eJRF), is open for completion since March 1st and it covers reporting data for 2022.

Vaccination 40

Vaccination Vaccine 40

Drug Discovery World

AUGUST 31, 2022

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumour-induced immunosuppression. Our immune systems are capable of destroying cancer cells, and several approved and experimental drugs stimulate cancer immunity. Co-authors also included Drs.

Research 52

Research Protein Gene Scientist 52

XTalks

APRIL 18, 2024

Understanding the Greens Powder Market The market for greens powders, often comprising ingredients like kale, spirulina and other superfoods, has been on health food shelves for decades. The greens powder market is largely driven by the growing consumer awareness of health and wellness, particularly gut health and immune support.

Marketing 52

Marketing Production Branding Regulation 52

pharmaphorum

AUGUST 31, 2022

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners.

Development 113

Development Drugs 113

Drug Discovery World

JANUARY 18, 2024

The results, together with the data from the recent LPS human challenge trial, further support the strategic expansion of the Phase II ready POLB 001 to treat and prevent cancer immunotherapy-induced CRS. Reductions were seen in all serum proinflammatory cytokines tested. million cases of cancer by 2030 1,2.

In-Vivo 64

In-Vivo Antibody Clinical Trials Clinical Trials 64

XTalks

NOVEMBER 30, 2023

The World Health Organization (WHO) has designated the theme of World AIDS Day 2023 as “Let Communities Lead.” According to the WHO, HIV continues to be a significant global public health concern, claiming the lives of 40.4 million individuals to date, with ongoing transmission occurring worldwide. In addition, Vir Biotechnology, Inc.

FDA Approval 111

FDA Approval Gene Therapy Clinical Trials Clinical Trials 111

Pharmaceutical Technology

AUGUST 1, 2022

While the need for vaccines and drugs appeared more urgent than ever during the pandemic, it is possible that there will be more severe public health crises in years to come. AMR occurs when disease-causing bacteria become resistant or immune to the antibiotics used to treat them. million direct deaths in 2019 and an additional 4.95

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

XTalks

SEPTEMBER 21, 2023

The trial’s primary objective is to assess the safety of VIR-1388 and its capacity to stimulate a specific immune response against HIV in study participants. This groundbreaking endeavor has received support from the National Institute of Allergy and Infectious Diseases (NIAID). mRNA, 2) BG505 MD39.3 gp151 mRNA and 3) BG505 MD39.3

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

The Pharma Data

JUNE 22, 2023

The main objectives of the collaboration will be to support global efforts to overcome inequities that millions of people face in accessing health services and attaining the highest levels of physical and mental health, and addressing the health-related challenges posed by climate change.

Development 40

Development 40

XTalks

MAY 30, 2023

Therefore, it is important to advocate for better services, highlight support networks and champion self-care. This also includes fundraisers and awareness campaigns aimed to bring attention to the needs of people living with MS and support continued research into causes, treatments and hopefully, a cure.

Genetics 98

Genetics Research Immune Response Drugs 98

BioTech 365

AUGUST 12, 2020

(TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, is pleased to … Continue reading →

Sales 40

Sales Life Science Production Development 40

pharmaphorum

JUNE 22, 2022

Six in 10 respondents to Health Union’s Spondyloarthritis In America 2021 survey said they feel other people in their lives don’t understand the risks of being immunocompromised. can be considered immunocompromised, meaning their immune system and their ability to fight infections and other diseases is weakened.

Scientist 52

Scientist 52

Drug Discovery World

DECEMBER 15, 2023

Professor Sir Andrew Pollard, Director of OVG and the Ashall Professor of Infection and Immunity at the Pandemic Sciences Institute, said: “The recent pandemic has highlighted the importance of making vaccines against potential threats to humanity.

Vaccination 59

Vaccination Vaccine Development Research 59